DC CFAR Investigators Dr. Irene Kuo and Dr. Marc Siegel lead Study on the Impact of Mobile Health Services on People who Inject Drugs (HPTN 094 INTEGRA Study) |
Please join us in congratulating DC CFAR Drug User Health SIG Co-Lead Dr. Irene Kuo and DC CFAR Investigator Dr. Marc Siegel, who will lead the HIV Prevention Trials Network (HPTN) INTEGRA study (HTPN 094) research team at George Washington University. The goal of the INTEGRA study is to "determine whether using mobile health units to deliver integrated health services can improve HIV and substance use outcomes among people with opioid use disorder who inject drugs." The GW team is one of five groups selected to join the study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) with funding from the National Institute on Drug Abuse (NIDA).
For more information on the INTEGRA Study click here and here for the full GW announcement.
|
|
Join the HANC Webinar: "A Conversation with Women Researchers" |
Join an upcoming webinar hosted by the The Legacy Project of the Office of HIV/AIDS Network Coordination and Women’s HIV Research Collaborative entitled "A Conversation with Women Researchers" on September 9 at 2 pm ET. The webinar will highlight work of women who are currently conducting HIV/AIDS research including DC CFAR SBS Core Director Dr. Lisa Bowleg (GW). The session is part of the “New Investigators Webinar Series” which aims to featuring the background, work and professional trajectory of underrepresented minority researchers in the United States.
|
|
Submit a Proposal: Innovative Community Engagement Strategies to Reduce HIV-Related Stigma and Disparities |
The Office of the Assistant Secretary for Health (OASH) Office of Infectious Disease and HIV/AIDS Policy (OIDP), the Office of Minority Health (OMH) is seeking proposals for the HIV Challenge on innovative approaches to improve PrEP and antiretroviral therapy (ART) utilization among racial and ethnical minority individuals who are at increased risk for HIV infection or are people with HIV (PWH). This challenge will provide an opportunity for individuals and organizations to develop novel programs that can be successfully implemented within their local communities.
For more information, click here.
|
|
|
Join the Wednesday Conversations with the DC CFAR CPS Core: Best Practices in Statistics |
Please join the DC CFAR for Wednesday Conversations with the Clinical and Population Sciences (CPS) Core on September 22 from 5:00 to 6:00 pm via Zoom. The session will feature a presentation from CPS Core Co-Director Dr. Sam Simmens (GW) who will discuss best practices for statistical analyses in research proposals. Register below to receive log-in details.
|
|
Announcing the Fall 2021 DC CFAR Pilot Awards Cycle: Presubmissions due September 9 |
The DC CFAR is pleased to announce the next round of soliciting research proposals through our Pilot Awards Program. The goal of the Pilot Awards Program is to provide pilot research funds to early stage and new HIV/AIDS investigators to collect preliminary data that will enable them to then compete successfully for NIH funding in HIV/AIDS as principal investigators. Please see the RFA for specific eligibility requirements.
Applications should focus on the NIH high priority HIV/AIDS research areas including HIV cure research; reducing HIV/AIDS incidence; the next generation of HIV therapies; HIV-associated comorbidities, coinfections, and complications; and cross-cutting areas of basic research and health disparities.
In addition, applications are strongly encouraged in the following DC CFAR priority areas of our Scientific Working Groups and Scientific Interest Groups:
- HIV Cure Research
- Ending the HIV Epidemic
- Drug User Health
- Women and HIV
- Aging and Comorbidities
- Latinx
- Global
- Sexual and Gender Minorities
Pre-submission forms are due September 9, 2021. For complete details about these funding opportunities, please visit our website.
If you have any questions regarding the application process, please contact Brandi Robinson.
|
|
|
The District of Columbia Clinical Trials Unit (DC CTU) is seeking input on how to better engage the community in the DC region in HIV research. This survey is anonymous and voluntary and aims to gather data on understanding and
improving local CABs. Click here to fill out the survey.
Do you have an event you would like to see included in the next edition of the Community Spotlight? We invite any news or updates from the DC CFAR community and encourage you to send information that may be of interest to CFARinDC@gmail.com. |
|
DC CFAR partner institutions and community-based organizations have developed numerous excellent COVID-19 resources. We've included a collection of these here, along with a number of other opportunities for your reference. We will continue to update these resources in the days ahead and we encourage you to send information that may be of interest to our DC CFAR community to CFARinDC@gmail.com.
The VA Medical Center in Washington, DC is recruiting two research nurses for NIH-funded COVID-19 studies on-site. Please review the position posting here for more information. The posting will close on September 7.
The amfAR HIV-COVID Recovery study is recruiting people living with HIV (or their HIV-negative friends, partners, etc) who have had a positive COVID-19 swab within the last month prior to enrollment in the study. For more information click here. |
|
September 7, 2021
September 9, 2021
September 21-22, 2021
September 22, 2021
September, 23-24, 2021
September 27, 2021
September 29- October 3, 2021
September 19-October 7, 2021
October 11-14, 2021
October 12-13, 2021
Abstracts are due September 3. For more information click here.
October 13-14, 2021
November 15-19, 2021
Washington, DC
Abstracts due October 1. For more information click here.
November 18-21, 2021
San Juan, PR
December 2-3, 2021
|
|
FUNDING, TRAINING AND MENTORING OPPORTUNITIES
|
|
The VA Medical Center in Washington, DC has two research nurse positions for NIH-funded COVID-19 studies on site. Please note that the postings will close on September 7.
The Inter-CFAR Implementation Science Working Group is accepting applications for an NIH-funded training opportunity in implementation science (IS) for early stage investigators (ESIs) engaging in HIV-related research. Interested applicants should apply online here by September 10.
NIH is requesting information from stakeholders on the utility and useability of sample language developed for use in informed consent documents for data and biospecimen sharing. Response to this Notice is voluntary. The deadline for responses is September 29, 2021.
|
|
NIH FUNDING OPPORTUNITIES
|
|
Funding Opportunity Number: RFA-CA-21-056
Posting Date: August 25, 2021
Closing Date: December 15, 2021
Funding Opportunity Number: RFA-AA-21-016
Posting Date: August 23, 2021
Closing Date: December 16, 2021
Funding Opportunity Number: RFA-MH-21-250
Posting Date: August 19, 2021
Closing Date: December 7, 2021
Funding Opportunity Number: RFA-AI-21-058
Posting Date: August 12, 2021
Closing Date: December 9, 2021
Funding Opportunity Number: RFA-DA-22-033
Posting Date: July 21, 2021
Closing Date: February 17, 2022
Funding Opportunity Number: PAR-21-258
Posting Date: July 16, 2021
Closing Date: September 10, 2021
Click here for additional funding opportunities available from the National Institutes of Health.
|
|
The DC CFAR is an NIH funded program (P30AI117970), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NIDCR, NHLBI, NIDA, NIMH, NIA, NIDDK, NINR, NIMHD, FIC, and OAR. The content isthe responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. |
|
|
|
|
|
|
|
|
